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Avoiding premature death in epilepsy
General practice is the place to start, and much can be done
Leone Ridsdale professor of neurology and general practice
Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Academic Neuroscience Centre, London
SE5 8AF, UK
An estimated 1.16 per 1000 people with epilepsy die suddenly
each year.1 In 2013 there were 680 deaths from epilepsy among
people aged under 75 (973 deaths at all ages) in England and
Wales.2 Sudden death in epilepsy peaks in young adults,
particularly men, so a 20 year old with epilepsy has a greater
than 1% risk of dying before he reaches 30, before adding other
known risks for sudden death. Comparing years of potential life
lost from neurological disease, epilepsy is second only to stroke.1
Research on this topic has focused on cohort studies1 and
whether risk should be explained to patients.3However, equally
important and currently unanswered questions are: can group
and individual risks for death be identified, perhaps using
patients’ routine electronic records? Are some identified risks
amenable to better medical management? Andwill cash strapped
governments pay for it?
Some deaths are unavoidable, but improved care might result
in fewer unnecessary, untimely deaths. General practitioners
routinely identify risks of heart disease and stroke in the UK
using electronic records and discuss themwith patients. National
strategy also supports risk identification for cancer in primary
care.4
With others, I conducted a pilot study that showed it was feasible
to identify specific risk factors for death in epilepsy, which had
been derived from cohort studies, using routine data from GPs’
electronic records.5 We found that people with epilepsy and
alcohol problems had an almost threefold increased risk of death.
The risk in patients who had not collected their most recent
anticonvulsant prescription in the past three to six months was
nearly doubled. Having “a history of injury” during the previous
year increased risk by 40%, and having had treatment for
depression increased risk by about the same.5
A European collaboration, AMIEHS (Avoidable Mortality in
the European Union: Towards Better Indicators for the
Effectiveness of Health Systems), has set up criteria to identify
causes of avoidable death and to compare outcomes across
Europe.6 Inclusion criteria for putative conditions are that death
rates must be over 100 a year and must have declined
somewhere by at least 30%.6 Cervical cancer and Parkinson’s
disease have already been included. Death rates from
Parkinson’s disease have fallen by 30%, but because the onset
of Parkinson’s disease is usually at an older age, many fewer
potential years of life are lost. The challenge is to develop and
evaluate interventions that reduce epilepsy mortality by at least
30%.
Identification of risk
Everyone with epilepsy has to be assessed in order to capture
those most at risk. In some Nordic countries, specialists provide
continuing care for people with epilepsy and have electronic
records.7 They can identify population, and potentially
individual, risks. An English study found that 20% of people
with epilepsy who died suddenly had been in contact with
specialist services in the previous year.8 About 90% of deaths
occurred in people with tonic-clonic seizures that had increased
in frequency in the previous three to six months. One half had
a record of alcohol misuse, and a quarter had been taking drugs
to treat depression or anxiety.8
Virtually every person in the United Kingdom is registered with
a GP. From 2004-14 GPs were remunerated for keeping a
register of people with epilepsy using their electronic records
and for reporting if patients were seizure-free. GPs also stored
more detailed information on the other risks that could affect
outcomes.What could researchers do to help GPs identify those
at higher risk of death in epilepsy? An in-depth analysis of
electronic records from 2004-14 would produce more precise
risk estimates. Risk assessment tools, which have already been
developed for other conditions presenting in primary care,4 could
evaluate individual symptoms and signs and visually present
combined risks, alerting GPs to “red flag” profiles. Such tools
should be developed and piloted for people with epilepsy, with
input from users.
What could GPs do as risk managers? As in other conditions,
individual risks differ and require specifically tailored step-up
care. GPs could monitor, manage, and, where necessary, refer
patients to community or secondary care teams. Patients who
do not collect their prescription could be automatically identified
and contacted directly, with reminders in primary care. Patients
with substancemisuse can be referred to local addiction services.
In a cohort study, 30% of deaths were unintentional, mostly
from drowning and burns.9 People with an injury linked to a
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seizure may present in primary care or in the emergency
department. This could trigger referral to an epilepsy nurse
specialist for advice on self management of risk.10
Death in epilepsy is associated with depression.7 A community
study found that people with epilepsy who report symptoms of
depression subsequently report poorer seizure control and that
this relation is bi-directional.11 Depressed people with epilepsy
are also less likely to adhere to their medications.12 A vicious
cyle of prior risks seems likely to accumulate, with seizures
leading to depression, depression leading to less effective
medication self managment, more frequent seizures, and a
cumulative risk of death. A risk assessment tool which added
the positive predictive values of each risk would alert GPs.
Screening for depression is good practice in several long term
conditions. This should include epilepsy. Antidepressants and
cognitive behavioural therapy might reduce depression and
improve self managment and could be tested in a trial.
This may seem a tall order. But up until 1988 GPs did not call
and recall people to check for the risk of cervical cancer.Women
who died had often never been checked.13 Since monitoring
began annual death rates have more than halved,13 and there are
now fewer deaths than the number for epilepsy.2 The NHS
estimates it spends £175m (€235m; $268m) a year on identifying
people at risk from cervical cancer, referral for closer
monitoring, and, if necessary, for surgical intervention.13General
practice is not the only place that the risk of death in epilepsy
can be identified in the UK, but since most of the risks are
non-neurological it is the right place to start.
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